Clinical Trials · NCT02291679

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

CompletedPhase 3Linaclotide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ironwood Pharmaceuticals, Inc.
Enrollment
1,223
Start date
Oct 2014
Locations
95 sites, United States
Primary endpoint
Percentage of 12-Week CSBM Overall Responders
View Linaclotide compound reference